Our company's mission is to care for health, immunity, vitality and well-being of people of all ages.
The company's activity began in 2002 in Pietrzykowice near Wrocław and as a Pharmaceutical and Cosmetic Oils Factory, the company specialized in the production of vegetable oils from seeds such as: primrose, borage and flax.
Today, Oleofarm is one of the largest pharmaceutical companies with Polish capital, which offers a wide range of cold-pressed oils, dietary supplements, juices, etc.
The headquarters of our company together with the production plant is located in Wrocław. The complex includes a production department with a versatile machine park, a quality control laboratory, a warehouse of raw materials, packaging and finished products as well as office rooms.
We also offer a number of services: encapsulation of hard capsules with loose and liquid packing, soft capsules encapsulation with liquid filling, grinding of flaxseed bagasse, hemp, etc., pressing of herbal plant seed oils on specialized presses allowing to maintain full nutritional values of oils, bottling and packaging liquid raw materials, spray drying, production of loose mixtures and their packaging, packaging of capsules.
10.89.Z - Manufacture of other food products not elsewhere classified
10.32.Z - Manufacture of fruit and vegetable juice
10.39.Z - Other processing and preserving of fruit and vegetables
10.41.Z - Manufacture of oils and other fluid fats
10.42.Z - Manufacture of margarine and similar edible fats
10.81.Z - Manufacture of sugar
11.07.Z - Manufacture of soft drinks; production of mineral waters and other bottled waters
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
47.11.Z - Retail sale in non-specialised stores with food, beverages or tobacco predominating
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Assets | 177,6 | 188,1 | 193,3 | 2,7 |
Gross profit (loss) | 35,8 | 10,1 | 16,4 | 62,6 |
Net profit (loss) | 28,6 | 8,2 | 13,1 | 59,7 |
Cash | 25 | 16,7 | 24,4 | 46,6 |
Liabilities and provisions for liabilities | 53,8 | 56,1 | 49,4 | -12 |
Net income from sale | 185 | 191,4 | 206,2 | 7,7 |
Short time liabilities | 34,2 | 38,2 | 35,3 | -7,4 |
Working assets | 78,9 | 88,2 | 94,2 | 6,8 |
Equity capital | 123,8 | 132 | 143,9 | 9 |
Operating profit (EBIT) | 35,4 | 9,5 | 18,2 | 91,2 |
% | % | % | p.p. | |
Equity capital to total assets | 69,7 | 70,2 | 74,5 | 4,3 |
Gross profit margin | 19,3 | 5,3 | 8 | 2,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 67 | 73 | 63 | -10 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane